NCT06707311

Brief Summary

The protection of the dentin-pulp complex consists of the application of one or more layers of specific material between the restorative material and dental tissue to avoid additional challenge to the pulp tissue caused by operative procedures, toxicity of restorative materials and bacteria penetration due to microleakage. Protection of the dentinpulp complex has also the function to recover pulp vitality.The materials that can be used for this purpose are varnishes,calcium hydroxide (CH)-based products, glass ionomer cements (GICs) and adhesive systems.The biological compatibility together with the sealing capabilities of dental materials is of paramount importance to avoid or limit pulp tissue irritation and dentinal hypersensitivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 27, 2024

Completed
Last Updated

November 27, 2024

Status Verified

November 1, 2024

Enrollment Period

6 months

First QC Date

November 21, 2024

Last Update Submit

November 23, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post operative hypersensitivity

    Quantitative Assessment by using Verbal analogue scale scoring from 0 - 4 where 0 indicates no pain and 4 indicates intensifying pain

    6 month

Secondary Outcomes (1)

  • Radiographic evaluation

    6 month

Study Arms (4)

patients received calcium hydroxide with resin composite

ACTIVE COMPARATOR

patients received calcium hydroxide lining material then restored with resin composite

Other: patients received calcium hydroxide with glass ionomer restorative material

patients received TheraCal LC with resin composite

ACTIVE COMPARATOR

patients received TheraCal LC lining material then restored with resin composite

Other: patients received TheraCal LC with glass ionomer restorative material

patients received universal bonding with resin composite

ACTIVE COMPARATOR

patients received universal bonding as lining material then restored with resin composite

Other: patients received universal bonding with glass ionomer restorative material

patients received bioactive bonding with resin composite

ACTIVE COMPARATOR

patients received bioactive bonding as lining material then restored with resin composite

Other: patients received bioactive bonding with glass ionomer restorative material

Interventions

patients received calcium hydroxide with glass ionomer restorative material

patients received calcium hydroxide with resin composite

patients received TheraCal LC with glass ionomer restorative material

patients received TheraCal LC with resin composite

patients received bioactive bonding with glass ionomer restorative material

patients received bioactive bonding with resin composite

patients received bioactive bonding with glass ionomer restorative material

patients received universal bonding with resin composite

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient's age ranges from 20-50 years old with vital first permanent molar tooth on testing by vitality test, such as thermal or electrical pulp tester.
  • Class I or II cavities.
  • Deep carious lesions.
  • Absence of clinical signs or symptoms suggesting non-vital tooth such as spontaneous pain, tenderness to percussion, abscess, fistula, periodontal tissue swelling, or abnormal tooth mobility.
  • Sufficient tooth structure for restoration.
  • Healthy patients with good general health.
  • Patients are cooperative and motivated.

You may not qualify if:

  • Patient with systemic diseases such as uncontrolled diabetic, cardiovascular diseases, or patient received chemotherapy or radiotherapy.
  • History of spontaneous, unprovoked toothache or mobility, (grade I, II and III).
  • Sensitivity to percussion, external or internal root resorption, periapical lesions or presence of a fistulae.
  • Pregnant females.
  • Drug abuser patients.
  • Previously restored teeth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Badr University in Cairo

Cairo, Egypt

Location

Study Officials

  • Ahmed A Abdelaziz, PhD

    BADR University in Cairo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in BADR University

Study Record Dates

First Submitted

November 21, 2024

First Posted

November 27, 2024

Study Start

February 1, 2024

Primary Completion

August 1, 2024

Study Completion

October 1, 2024

Last Updated

November 27, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations